8 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents ... #Diabetes #Diabetic ... #Medications #Pharmacology ... #Dosing #Dosing ... Impairment #CKD #Table
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... drugs. ... #pharmacology #dm2 ... #diabetes #medications ... #overview #management
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Initiative (PAMI) - Non-Opioid ... Analgesics - Agents ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Table #PAMI
Statins intensity, drug interactions, timing of administration and missed doses.

An overview of high, moderate and low
Statins intensity, drug ... An overview of high ... #pharmacology #overview ... #medications #comparison ... #drugs #table
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... 4/11/2020 #Drugs ... #Medications #Treatment ... #Table #Management
The 8 A’s — drugs that interact with warfarin
Antibiotics 
 - Most agents, but especially co-trimoxazole,
The 8 A’s — drugs ... with warfarin Antibiotics ... #Interactions #Table ... Mnemonic #8As #Pharmacology ... #Medications
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... #pharmacology #antibiotics ... #medications #table ... #treatment #drugs
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... to remain stable ... #semaglutide #Diabetes ... #Pharmacology #